| Issue | Title | |
| Vol 1, Issue 2 (2021) | Perspectives of personalized approach to prevention and treatment of anticonvulsant-induced osteoporosis via action on vitamin D exchange and VDR expression | Abstract PDF (Eng) |
| E. A. Dontseva, V. V. Trefilova, T. E. Popova, M. M. Petrova, M. Al-Zamil | ||
| Vol 3, Issue 2 (2023) | Pharmacogenetic Factors of Clozapine-Induced Metabolic Syndrome | Abstract PDF (Eng) |
| A. K. Khasanova | ||
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) |
| S M. Osipova, N. A. Shnayder | ||
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) |
| A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 2, Issue 2 (2022) | Pharmacogenetic Testing of Cytochrome P450 System Enzymes in the Therapy of Bipolar Affective Disorder | Abstract PDF (Eng) |
| A. K. Khasanova, R. F. Nasyrova | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism | Abstract PDF (Eng) |
| E. E. Vaiman, M. A. Novitsky, R. F. Nasyrova | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of fluoxetine | Abstract PDF (Eng) |
| M. A. Novitsky, S. D. Skopin, V. V. Kravtsov | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of quetiapine | Abstract PDF (Eng) |
| A. K. Abdyrakhmanova, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 2, Issue 1 (2022) | Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing | Abstract PDF (Eng) |
| N. A. Shnayder, A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 3, Issue 2 (2023) | Phenocopy of Amyotrophic Lateral Sclerosis in Patients with Chiari 1 Malformation Associated Syringomyelia: Brief Literature Review | Abstract PDF (Eng) |
| M. Al-Zamil, N. G. Kulikova | ||
| 71 - 80 of 105 Items | << < 3 4 5 6 7 8 9 10 11 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Alzheimer's disease
Parkinson's disease
adverse drug reactions
adverse reaction
antipsychotic
antipsychotics
anxiety
biomarkers
candidate genes
epilepsy
genetics
long QT syndrome
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
treatment
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
